Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles
Most GLP-1 agonists do not require dose adjustment for mild to moderate renal impairment, though specific agents have varying recommendations for severe impairment
Canagliflozin was associated with a decrease in total hip bone mineral density over 104 weeks, (placebo-subtracted changes:100mg -0.9% and 300mg -1.2%), but did not result in changes in bone mineral density in the femoral neck, lumbar spine, or distal forearm (227)
As of May 2024, Novo Nordisk had a market value of $570 billion, making it bigger than the entire economy of Denmark
A muscle mass in a patient with polymyalgia rheumatica
Basic metabolic panel before starting is smart practice